BACE1 and Alzheimer disease: Long-term administration of TSG to AD model mice can reduce the expression of BACE1 and PS1, which can improve the learning, memory and cognition of mice by inhibiting the activity of γ-secretase and reducing the cleavage of Aβ (Chen, 2017).